© The Author 2006. Published by Oxford University Press. All rights reserved. For Permissions, please e-mail: journals.permissions@oxfordjournals.org.
Chapter 13: A Comparative Review of CISNET Breast Models Used To Analyze U.S. Breast Cancer Incidence and Mortality Trends
Affiliations of authors: Cornerstone Systems, Lynden, WA (LDC); Department of Radiology, Stanford University, Stanford, CA (SKP); Rand Corporation, Santa Monica, CA (RB); Statistical Research and Application Branch, Division of Cancer Control and Population Sciences, National Cancer Institute, Bethesda, MD (KAC, EJF)
Correspondence to: Lauren D. Clarke, MS, Cornerstone Systems Northwest Inc., 8665 Berthusen Rd., Lynden, WA 98264 (e-mail: lauren{at}cornerstonenw.com).
The CISNET Breast Cancer program is a National Cancer Institutesponsored collaboration composed of seven research groups that have modeled the impact of screening and adjuvant treatment on trends in breast cancer incidence and mortality over the period 19752000 (base case). This collaboration created a unique opportunity to make direct comparison of results from different models of population-based cancer screening produced in response to the same question. Comparing results in all but the most cursory way necessitates comparison of the models themselves. Previous chapters have discussed the models individual in detail. This chapter will aid the reader in understanding key areas of difference between the models. A focused analysis of differences and similarities between the models is presented with special attention paid to areas deemed most likely to contribute substantially to the results of the target analysis.
This article has been cited by other articles:
![]() |
J. S. Mandelblatt, K. A. Cronin, S. Bailey, D. A. Berry, H. J. de Koning, G. Draisma, H. Huang, S. J. Lee, M. Munsell, S. K. Plevritis, et al. Effects of Mammography Screening Under Different Screening Schedules: Model Estimates of Potential Benefits and Harms Ann Intern Med, November 17, 2009; 151(10): 738 - 747. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. J. Feuer Chapter 1: Modeling the Impact of Adjuvant Therapy and Screening Mammography on U.S. Breast Cancer Mortality Between 1975 and 2000: Introduction to the Problem J Natl Cancer Inst Monographs, October 1, 2006; 2006(36): 2 - 6. [Full Text] [PDF] |
||||
![]() |
J. D. F. Habbema, S. Y. G. L. Tan, and K. A. Cronin Chapter 14: Impact of Mammography on U.S. Breast Cancer Mortality, 1975-2000: Are Intermediate Outcome Measures Informative? J Natl Cancer Inst Monographs, October 1, 2006; 2006(36): 105 - 111. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. A. Cronin, E. J. Feuer, L. D. Clarke, and S. K. Plevritis Chapter 15: Impact of Adjuvant Therapy and Mammography on U.S. Mortality From 1975 to 2000: Comparison of Mortality Results From the CISNET Breast Cancer Base Case Analysis J Natl Cancer Inst Monographs, October 1, 2006; 2006(36): 112 - 121. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. D. F. Habbema, C. B. Schechter, K. A. Cronin, L. D. Clarke, and E. J. Feuer Chapter 16: Modeling Cancer Natural History, Epidemiology, and Control: Reflections on the CISNET Breast Group Experience J Natl Cancer Inst Monographs, October 1, 2006; 2006(36): 122 - 126. [Full Text] [PDF] |
||||

